FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:938-949 August 28, 2008 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set Video Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, . . . [Full Text of this Article]

Formation of a Platelet Thrombus

Two Independent Pathways to Platelet Activation

Propagation of the Platelet Thrombus

Blood Coagulation

Tissue Factor

Thrombin and Fibrin

Tissue Factor and Microparticles in Thrombotic Disorders

Hemostatic Microparticles versus Pathologic Microparticles

Cancer-Associated Thrombosis

Paroxysmal Nocturnal Hemoglobinuria

Atherothrombosis

New Strategies for Antithrombotic Agents

Source Information

From the Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, and Harvard Medical School — both in Boston.

This article has been cited by other articles:

• Sopov, V., Bernstine, H., Stern, D., Yefremov, N., Sosna, J., Groshar, D. (2009). The Metabolic Spectrum of Venous Thrombotic Disorders Found on PET/CT. Am. J. Roentgenol. 193: W530-W539 [Abstract] [Full Text]  
• Angiolillo, D. J., Capodanno, D., Goto, S. (2009). Platelet thrombin receptor antagonism and atherothrombosis. Eur Heart J 0: ehp504v1-ehp504 [Abstract] [Full Text]  
• Zwicker, J. I., Liebman, H. A., Neuberg, D., Lacroix, R., Bauer, K. A., Furie, B. C., Furie, B. (2009). Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy. Clin. Cancer Res. 15: 6830-6840 [Abstract] [Full Text]  
• Lyman, G. H., Khorana, A. A. (2009). Cancer, Clots and Consensus: New Understanding of an Old Problem. JCO 27: 4821-4826 [Full Text]  
• Collet, J.-P., Montalescot, G. (2009). Review: Platelet Function Testing and Implications for Clinical Practice. J CARDIOVASC PHARMACOL THER 14: 157-169 [Abstract]  
• Seehaus, S., Shahzad, K., Kashif, M., Vinnikov, I. A., Schiller, M., Wang, H., Madhusudhan, T., Eckstein, V., Bierhaus, A., Bea, F., Blessing, E., Weiler, H., Frommhold, D., Nawroth, P. P., Isermann, B. (2009). Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1-, Phospholipase-C{beta}-, Phosphoinositide 3-Kinase-, and Nitric Oxide-Dependent Signaling in Monocytes and Promotes Plaque Stability. Circulation 120: 774-784 [Abstract] [Full Text]  
• Verstuyft, C., Simon, T., Kim, R. B. (2009). Personalized medicine and antiplatelet therapy: ready for prime time?. Eur Heart J 30: 1943-1963 [Full Text]  
• Chen, B., Guo, L., Fan, C., Bolisetty, S., Joseph, R., Wright, M. M., Agarwal, A., George, J. F. (2009). Carbon Monoxide Rescues Heme Oxygenase-1-Deficient Mice from Arterial Thrombosis in Allogeneic Aortic Transplantation. Am. J. Pathol. 175: 422-429 [Abstract] [Full Text]  
• Romney, G., Glick, M. (2009). An Updated Concept of Coagulation With Clinical Implications. Journal of the American Dental Association 140: 567-574 [Abstract] [Full Text]  
• Rivera, J., Lozano, M. L., Navarro-Nunez, L., Vicente, V. (2009). Platelet receptors and signaling in the dynamics of thrombus formation. haematol 94: 700-711 [Abstract] [Full Text]  
• Mackman, N. (2009). On the Trail of Microparticles. Circ. Res. 104: 925-927 [Full Text]  
• Braun, A., Varga-Szabo, D., Kleinschnitz, C., Pleines, I., Bender, M., Austinat, M., Bosl, M., Stoll, G., Nieswandt, B. (2009). Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 113: 2056-2063 [Abstract] [Full Text]